Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2024 | Novel therapeutics to repair damage in multiple sclerosis

Alicja Kalinowska • 30 Jun 2024
EAN 2024
Multiple Sclerosis and Related Disorders

Alicja Kalinowska, MD, PhD, Poznan University of Medical Sciences, Poznań, Poland, discusses the development of novel therapeutics to repair existing damage in multiple sclerosis (MS).Several ongoing studies are looking to repurpose drugs to stimulate regeneration and remyelination, such as simvastatin and clemastine. This interview took place at the European Academy of Neurology (EAN) Annual Meeting 2024 in Helsinki, Finland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Alicja Kalinowska

Distinguishing true early MS pathology from coincidental or non-specific pre-diagnostic features
2:52
Distinguishing true early MS pathology from coincidental or non-specific pre-diagnostic features
Alicja Kalinowska • 28 Jun 2026
A debate at EAN 2026: does prodromal MS exist?
2:23
A debate at EAN 2026: does prodromal MS exist?
Alicja Kalinowska • 28 Jun 2026
Similarities between CIDP and MS and NMOSD
1:46
Similarities between CIDP and MS and NMOSD
Alicja Kalinowska • 30 Jun 2024
Evaluating progression in MS
4:10
Evaluating progression in MS
Alicja Kalinowska • 30 Jun 2024

Related Videos

A portable MRI device: improving access to care with applications in MS and stroke
1:07
A portable MRI device: improving access to care with applications in MS and stroke
Anthony Traboulsee • 28 Jun 2026
Distinguishing true early MS pathology from coincidental or non-specific pre-diagnostic features
2:52
Distinguishing true early MS pathology from coincidental or non-specific pre-diagnostic features
Alicja Kalinowska • 28 Jun 2026
A debate at EAN 2026: does prodromal MS exist?
2:23
A debate at EAN 2026: does prodromal MS exist?
Alicja Kalinowska • 28 Jun 2026
Approaches to improving the quality of life of patients with MS during the menopause
1:13
Approaches to improving the quality of life of patients with MS during the menopause
Celia Oreja-Guevara • 29 Jun 2026
The content of VJNeurology is intended for healthcare professionals